Drugs on the brain with Professor David Nutt

In this episode, we’re joined by leading neuropsychopharmacologist, Professor David Nutt, for a deep dive into the human brain and its relationship with drugs. We discuss whether our brains are built to consume drugs; whether modern society is changing the brain's neurochemistry and making people more vulnerable to substance use; how benzodiazepines work on the brain; and whether there will ever be a 'methadone equivalent' for stimulants such as cocaine?

We also draw upon Prof. Nutt's experience within the political arena, as the former chair of the Advisory Council of the Misuse of Drugs (ACMD). We discuss what impact the potential reclassification of ketamine, to a Class A drug, may have. Alongside this, we explore whether the Green Party’s call to legalise and regulate all drugs is shifting the debate into the mainstream, challenging the idea that progressive drug reform is a political risk.

If you have been affected by the issues discussed in this episode, please visit barod.cymru and confidentially chat to a trained support worker via Barod's Live Webchat Service, that is open 7-days a week, or call Dan 24/7, Wales' national drug and alcohol helpline on 0808 808 2234 or text DAN to 81066.

Note: The Advisory Council on the Misuse of Drugs (ACMD) makes recommendations to government on the control of dangerous or otherwise harmful drugs, including classification and scheduling under the Misuse of Drugs Act 1971 and its regulations. ACMD is an advisory non-departmental public body, sponsored by the Home Office.

Contents of the video:

(00:00) Highlights of the episode

(01:04) Introduction

(02:34) The power of the brain

(04:53) Why does understanding the brain matter when it comes to human behaviour?

(09:00) Is the brain built to consume drugs?

(13:23) Is modern society shaping our neurochemistry?

(21:36) Do we know everything there is to know about drugs on the brain?

(26:42) Pharmacological treatment for stimulant use and other drugs

(33:27) Benzodiazepines

(40:52) Reclassifying ketamine

(48:15) Green Party's policy to regulate all drugs and previous political broken promises

(52:49) Quickfire Q&A

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(62)

What is sober curiosity? With Scott Woolley (Arclett)

What does it mean to question our relationship with alcohol? Founder and Director of Arclett, Scott Woolley, joins Drugs Unwrapped to share his personal journey to becoming alcohol-free and explore th...

29 Sep 37min

Bringing young people's voices to the drug policy table with Ruby Rose Lawlor

We are joined by YouthRise's Executive Director, Ruby Rose Lawlor, to discuss influencing drug policy change at the UN, full spectrum harm reduction and the recent recommendation to decriminalise drug...

14 Sep 52min

Developing digital infrastructure within harm reduction with Mark Tudor

In this episode, we are joined by Mark Tudor, co-founder of Substancy. Mark has worked in the harm reduction field for over 30 years, but most recently has established Substancy, a social enterprise t...

1 Jul 30min

What is trauma-informed practice?

We are joined by Sarah, CAVDAS Alliance Manager, to shed light on what trauma-informed practice is and why it matters. Sarah has led Barod's journey towards becoming a trauma-informed organisation and...

17 Jun 37min

Image and Performance Enhancing Drugs: What's the appeal?

In this episode, we are joined by Liberty Musungo, Image and Performance Enhancing Drugs (IPEDs) Lead for Dyfed Drug and Alcohol Service (DDAS). Liberty takes us through what IPEDs are and how they wo...

2 Jun 45min

How do we become anti-stigma?

In this Learning at Work Week special, we are joined by Barod's Operations Manager, Sian, to discuss how we can move from being non-stigmatising, to actively challenging and becoming anti-stigma.In th...

19 Mai 23min

Inside the Green Party’s Plan to Legalise Drugs

In this episode, we are joined by Dr. Carrie Hamilton and Michael Wakelyn-Green, from the Green Party Drug Policy Working Group, to explore the party's proposed approach to drug policy. With recent fo...

21 Apr 43min